BCL9L Antibody (YA7105)

Cat. No.: HY-P87417: Data Sheet COA
SDS
User Guide for Antibodies
FAQs
Technical Support

BCL9L Antibody (YA7105) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to BCL9L.

For research use only. We do not sell to patients.

Size	Stock	Quantity
20 μL	In-stock	Estimated Time of Arrival: December 31
50 μL	In-stock	Estimated Time of Arrival: December 31
100 μL	In-stock	Estimated Time of Arrival: December 31
250 μL	Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

WB: Western Blot;
IHC-P: Immunohistochemistry-Paraffin;
IHC-F: Immunohistochemistry-Frozen;
ICC/IF: Immunocytochemistry/Immunofluorescence;
IF-Tissue: Immunofluorescence-Tissue;
mIHC: Multiplex Immunohistochemical;
IP: Immunoprecipitation;
ChIP: Chromatin Immunoprecipitation;
FC: Flow Cytometry;
ELISA: Enzyme Linked Immunosorbent Assay

Product Detail
Background
Documentation

Description

BCL9L Antibody (YA7105) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to BCL9L.

Host

Mouse

Clonality

Monoclonal

Molecular Weight

Predicted band size: 157kDa;

Species Reactivity

Human

SwissProt ID

Q86UU0

Immunogen

Purified recombinant fragment of human BCL9L (AA: 606-751) expressed in E. Coli.

Application &
Dilution Ratio

Application	Dilution Ratio
FC FC: Flow Cytometry	1:200-1:400
ELISA ELISA: Enzyme Linked Immunosorbent Assay	1:10000

Sensitivity	Endogenous	Purity	affinity purified.
Conjugation	Non-conjugated	Modification	Unmodified
Isotype	IgG1

Appearance

Liquid

Formulation

Supplied in PBS with 0.05% sodium azide

Storage & Stability

Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

Shipping

Shipping with blue ice.

Background

Function：Transcriptional regulator that acts as an activator. Promotes beta-catenin transcriptional activity. Plays a role in tumorigenesis. Enhances the neoplastic transforming activity of CTNNB1 (By similarity)

Subcellular Localization：Nucleus

Expression：
Tissue_Specificity: Expressed in breast, ductal and invasive ductal carcinomas of the breast, sporadic colorectal adenomas and carcinomas (at protein level). Expressed in fetal brain. Expressed in lung, amygdala, eye, prostate, pancreatic and prostate cancers, head and neck tumors and embryonal tumor

Isoforms & Post-Translational Modification：Q86UU0 has four isomers: Q86UU0-1: 157129 Da (predicted); Q86UU0-2: 156529 Da (predicted); Q86UU0-3: 145906 Da (predicted); Q86UU0-4: 152547 Da (predicted).

Subunit：Found in a complex with CDC73; CTNNB1 and PYGO1

Database

SwissProt: SwissProt: Q86UU0

Documentation

Select Batch:

Data Sheet (230 KB) SDS (251 KB)

COA (205 KB)

User Guide for Antibodies (1077 KB)